Newswise News from Johns Hopkins Medicine billing Latest news from Johns Hopkins Medicine on Newswise en-us Copyright 2024 Newswise Newswise News from Johns Hopkins Medicine 115 31 / /images/newswise-logo-rss.gif Study Suggests a Healthy Diet May Help Keep Low Grade Prostate Cancer from Progressing to More Dangerous States During Active Surveillance /articles/study-suggests-a-healthy-diet-may-help-keep-low-grade-prostate-cancer-from-progressing-to-more-dangerous-states-during-active-surveillance/?sc=rsin /articles/study-suggests-a-healthy-diet-may-help-keep-low-grade-prostate-cancer-from-progressing-to-more-dangerous-states-during-active-surveillance/?sc=rsin Thu, 17 Oct 2024 13:00:12 EST In a peer-reviewed study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific evidence that a healthy diet may reduce the chance of low risk prostate cancer progressing to a more aggressive state in men undergoing active surveillance -- a clinical option in which men with lower risk cancer are carefully monitored for progression in lieu of treatments that could have undesired side effects or complications. Johns Hopkins Medicine Study Finds HIV-To-HIV Kidney Transplants Are as Safe and Effective as Those Using Organs From Donors Without HIV /articles/study-finds-hiv-to-hiv-kidney-transplants-are-as-safe-and-effective-as-those-using-organs-from-donors-without-hiv/?sc=rsin /articles/study-finds-hiv-to-hiv-kidney-transplants-are-as-safe-and-effective-as-those-using-organs-from-donors-without-hiv/?sc=rsin Wed, 16 Oct 2024 17:15:29 EST According to findings from a multicenter study led by Johns Hopkins Medicine and released today in The New England Journal of Medicine (NEJM), transplanting kidneys from deceased donors who had the human immunodeficiency virus (HIV) to recipients with HIV is safe. Perhaps more importantly, the study authors also found that HIV-to-HIV kidney transplants are comparable in effectiveness to those using organs from donors without HIV. Johns Hopkins Medicine Immune Signatures May Predict Adverse Events from Immunotherapy /articles/immune-signatures-may-predict-adverse-events-from-immunotherapy/?sc=rsin /articles/immune-signatures-may-predict-adverse-events-from-immunotherapy/?sc=rsin Tue, 15 Oct 2024 13:00:45 EST Distinct immune "signatures" in patients who develop adverse events while taking immunotherapy for cancer may help oncologists identify patients at risk and treat them early to prevent serious side effects, suggests a study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy. Johns Hopkins Medicine Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models /articles/experimental-cancer-drug-eliminates-bones-metastases-caused-by-breast-cancer-in-lab-models/?sc=rsin /articles/experimental-cancer-drug-eliminates-bones-metastases-caused-by-breast-cancer-in-lab-models/?sc=rsin Tue, 15 Oct 2024 09:00:02 EST In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to help treat other types of cancer and viral illnesses. Johns Hopkins Medicine Johns Hopkins Medicine Study Finds Commonly Used Arm Positions Can Substantially Overestimate Blood Pressure Readings /articles/johns-hopkins-medicine-study-finds-commonly-used-arm-positions-can-substantially-overestimate-blood-pressure-readings/?sc=rsin /articles/johns-hopkins-medicine-study-finds-commonly-used-arm-positions-can-substantially-overestimate-blood-pressure-readings/?sc=rsin Mon, 07 Oct 2024 11:00:00 EST Investigators say failing to follow arm support guidelines during BP screening could have significant clinical impact Johns Hopkins Medicine Johns Hopkins Joins Cancer AI Alliance /articles/johns-hopkins-joins-cancer-ai-alliance/?sc=rsin /articles/johns-hopkins-joins-cancer-ai-alliance/?sc=rsin Thu, 03 Oct 2024 13:00:32 EST Harnessing the power of artificial intelligence (AI) will enable new strategies for tackling cancer in a collaborative venture that brings together team science and vast data resources. Johns Hopkins Medicine James and Heather Gills Donate $10 Million to Wilmer Eye Institute, Johns Hopkins Medicine /articles/james-and-heather-gills-donate-10-million-to-wilmer-eye-institute-johns-hopkins-medicine/?sc=rsin /articles/james-and-heather-gills-donate-10-million-to-wilmer-eye-institute-johns-hopkins-medicine/?sc=rsin Thu, 03 Oct 2024 12:05:19 EST James and Heather Gills have donated $10 million to the Wilmer Eye Institute, Johns Hopkins Medicine, for establishment of a new center at Wilmer: the James P. Gills Jr., M.D., & Heather Gills Artificial Intelligence Innovation Center. Johns Hopkins Medicine Study of Monkey Fossils Found in Cave Sheds Light on the Animals' Extinction Centuries Ago /articles/study-of-monkey-fossils-found-in-cave-sheds-light-on-the-animals-extinction-centuries-ago/?sc=rsin /articles/study-of-monkey-fossils-found-in-cave-sheds-light-on-the-animals-extinction-centuries-ago/?sc=rsin Wed, 02 Oct 2024 11:05:20 EST By studying rare fossils of jaws and other skull parts of a long-extinct Caribbean monkey, a team of researchers that includes a Johns Hopkins University School of Medicine professor says it has uncovered new evidence documenting the anatomy and ecology of an extinct primate once found on Hispaniola -- the Caribbean island on which Haiti and the Dominican Republic are located. Johns Hopkins Medicine Clinical Trial Shows Synthetic Cannabis Reduces Agitation in Alzheimer's Disease /articles/clinical-trial-shows-synthetic-cannabis-reduces-agitation-in-alzheimer-s-disease/?sc=rsin /articles/clinical-trial-shows-synthetic-cannabis-reduces-agitation-in-alzheimer-s-disease/?sc=rsin Wed, 02 Oct 2024 10:00:30 EST In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in patients with Alzheimer's by an average of 30%. Johns Hopkins Medicine New Study: Neuroscientists Spark Shelter-Seeking Response by Reactivating Memory Circuit /articles/new-study-neuroscientists-spark-shelter-seeking-response-by-reactivating-memory-circuit/?sc=rsin /articles/new-study-neuroscientists-spark-shelter-seeking-response-by-reactivating-memory-circuit/?sc=rsin Tue, 01 Oct 2024 12:05:52 EST Using a sophisticated brain-imaging system, neuroscientists at Johns Hopkins Medicine say they have successfully reactivated a specific memory circuit in mice, causing them to seek out shelter when no shelter is actually present. Johns Hopkins Medicine Johns Hopkins Children's Center Expert Available to Discuss Sudden Infant Death Syndrome /articles/johns-hopkins-children-s-center-expert-available-to-discuss-sudden-infant-death-syndrome/?sc=rsin /articles/johns-hopkins-children-s-center-expert-available-to-discuss-sudden-infant-death-syndrome/?sc=rsin Tue, 01 Oct 2024 10:00:35 EST About 3,700 babies died suddenly and unexpectedly in the United States in 2022, according to the Centers for Disease Control and Prevention. More than one out of three of those deaths wer due to sudden infant death syndrome (SIDS) -- the unexplained death of a healthy baby less than 1 year old. Johns Hopkins Medicine AI 'Liquid Biopsies' Using Cell-Free DNA, Protein Biomarkers, Could Aid Early Detection of Ovarian Cancer /articles/ai-liquid-biopsies-using-cell-free-dna-protein-biomarkers-could-aid-early-detection-of-ovarian-cancer/?sc=rsin /articles/ai-liquid-biopsies-using-cell-free-dna-protein-biomarkers-could-aid-early-detection-of-ovarian-cancer/?sc=rsin Mon, 30 Sep 2024 09:00:00 EST A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help screen women for early signs of ovarian cancer, according to a study by researchers at the Johns Hopkins Kimmel Cancer Center in collaboration with several other institutions in the United States and Europe. Johns Hopkins Medicine New Study Mapping Stem Cells Reveals Molecular Choreography Behind Individual Variation in Human Development /articles/new-study-mapping-stem-cells-reveals-molecular-choreography-behind-individual-variation-in-human-development/?sc=rsin /articles/new-study-mapping-stem-cells-reveals-molecular-choreography-behind-individual-variation-in-human-development/?sc=rsin Wed, 25 Sep 2024 11:00:08 EST Researchers at the Johns Hopkins University School of Medicine have mapped variation in human stem cells that explains how cells of an individual may shape a unique "developmental dance" at the molecular level, thereby controlling how the brain and body are created. Johns Hopkins Medicine Specially Designed Video Games May Benefit Mental Health of Children and Teenagers /articles/specially-designed-video-games-may-benefit-mental-health-of-children-and-teenagers/?sc=rsin /articles/specially-designed-video-games-may-benefit-mental-health-of-children-and-teenagers/?sc=rsin Tue, 24 Sep 2024 14:00:52 EST In a review of previous studies, a Johns Hopkins Children's Center team concludes that some video games created as mental health interventions can be helpful - if modest - tools in improving the mental well-being of children and teens with anxiety, depression and attention-deficit/hyperactivity disorder (ADHD). Johns Hopkins Medicine Low Gravity in Space Travel Found to Weaken and Disrupt Normal Rhythm in Heart Muscle Cells /articles/low-gravity-in-space-travel-found-to-weaken-and-disrupt-normal-rhythm-in-heart-muscle-cells/?sc=rsin /articles/low-gravity-in-space-travel-found-to-weaken-and-disrupt-normal-rhythm-in-heart-muscle-cells/?sc=rsin Mon, 23 Sep 2024 15:00:00 EST Johns Hopkins Medicine scientists who arranged for 48 human bioengineered heart tissue samples to spend 30 days at the International Space Station report evidence that the low gravity conditions in space weakened the tissues and disrupted their normal rhythmic beats when compared to earth-bound samples from the same source. Johns Hopkins Medicine A Common Culprit Drives Prostate Cancer Progression /articles/a-common-culprit-drives-prostate-cancer-progression/?sc=rsin /articles/a-common-culprit-drives-prostate-cancer-progression/?sc=rsin Thu, 19 Sep 2024 11:00:38 EST By tracking the changes in prostate cancer cells over time, researchers at the Johns Hopkins Kimmel Cancer Center have found that activation of the MYC gene -- a well-known cancer-causing gene -- sets off a cascade of events that leads to both initiation and progression of the disease. Johns Hopkins Medicine News Tip: September Is Sickle Cell Awareness Month - Johns Hopkins Medicine Experts Are Available for Interviews /articles/news-tip-september-is-sickle-cell-awareness-month-johns-hopkins-medicine-experts-are-available-for-interviews2/?sc=rsin /articles/news-tip-september-is-sickle-cell-awareness-month-johns-hopkins-medicine-experts-are-available-for-interviews2/?sc=rsin Mon, 16 Sep 2024 10:05:23 EST September is National Sickle Cell Awareness Month. Experts from Johns Hopkins Medicine who specialize in sickle cell disease are available to discuss health equity issues related to sickle cell disease. Johns Hopkins Medicine Nadia Hansel Named Director of Johns Hopkins Department of Medicine /articles/nadia-hansel-named-director-of-johns-hopkins-department-of-medicine/?sc=rsin /articles/nadia-hansel-named-director-of-johns-hopkins-department-of-medicine/?sc=rsin Thu, 12 Sep 2024 12:45:53 EST Nadia Hansel, M.D., a pulmonary and critical care physician and expert in the environmental determinants of obstructive lung diseases, has been named director of the Department of Medicine at the Johns Hopkins University School of Medicine and physician-in-chief of The Johns Hopkins Hospital. Hansel is the William Osler Professor of Medicine. She is the first woman to lead the storied Department of Medicine in its 131-year history. Johns Hopkins Medicine Brenda Banwell Named Pediatrician-in-Chief and Co-Director of Johns Hopkins Children's Center /articles/renda-banwell-named-pediatrician-in-chief-and-co-director-of-johns-hopkins-children-s-center/?sc=rsin /articles/renda-banwell-named-pediatrician-in-chief-and-co-director-of-johns-hopkins-children-s-center/?sc=rsin Mon, 09 Sep 2024 10:00:19 EST Brenda Banwell, M.D., has been named pediatrician-in-chief and co-director of Johns Hopkins Children's Center. She also serves as director of the Department of Pediatrics at the Johns Hopkins University School of Medicine. Banwell began in the position on Sept. 1, 2024. Johns Hopkins Medicine Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence /articles/immunotherapy-before-and-after-lung-cancer-surgery-reduces-death-risk-disease-recurrence/?sc=rsin /articles/immunotherapy-before-and-after-lung-cancer-surgery-reduces-death-risk-disease-recurrence/?sc=rsin Sun, 08 Sep 2024 13:05:00 EST People with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to a new analysis by Johns Hopkins Kimmel Cancer Center investigators. Johns Hopkins Medicine